Attached files

file filename
8-K - 8-K - COHERENT INCa11-28991_18k.htm

Exhibit 99.1

 

@coherent

PRESS RELEASE

Editorial Contact:

For Release:

Leen Simonet

IMMEDIATE

(408) 764-4161

November 2, 2011

 

No. 1310

 

Coherent, Inc. Reports Fourth Fiscal Quarter and Year-End Results

 

SANTA CLARA, CA, November 2, 2011 — Coherent, Inc. (NASDAQ, COHR), a world leader in providing photonics based solutions to the commercial and scientific research markets, today announced financial results for its fourth fiscal quarter and year ended October 1, 2011.

 

FINANCIAL HIGHLIGHTS

 

 

 

Three Months Ended

 

Year Ended

 

 

 

Oct. 1,

 

July 2,

 

Oct. 2,

 

Oct. 1,

 

Oct. 2,

 

 

 

2011

 

2011

 

2010

 

2011

 

2010

 

GAAP Results

 

 

 

 

 

 

 

 

 

 

 

(in millions except per share data)

 

 

 

 

 

 

 

 

 

 

 

Bookings

 

$

195.4

 

$

228.5

 

$

192.5

 

$

895.0

 

$

696.0

 

Net sales

 

$

208.0

 

$

210.9

 

$

166.4

 

$

802.8

 

$

605.1

 

Net income

 

$

31.4

 

$

19.0

 

$

9.9

 

$

93.2

 

$

36.9

 

Diluted EPS

 

$

1.25

 

$

0.74

 

$

0.39

 

$

3.66

 

$

1.47

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Results

 

 

 

 

 

 

 

 

 

 

 

(in millions except per share data)

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

24.2

 

$

21.1

 

$

14.9

 

$

88.1

 

$

48.1

 

Diluted EPS

 

$

0.96

 

$

0.83

 

$

0.59

 

$

3.46

 

$

1.92

 

 

FOURTH FISCAL QUARTER DETAILS

 

For the fourth fiscal quarter ended October 1, 2011, Coherent announced net sales of $208.0 million and net income, on a U.S. generally accepted accounting principles (GAAP) basis, of $31.4 million, or $1.25 per diluted share.  These results compare to net sales of $166.4 million and net income of $9.9 million, or $0.39 per diluted share, for the fourth quarter of fiscal 2010.  Coherent’s tax expense for the fourth fiscal quarter of 2011 was reduced by approximately $9.7 million due to the release of tax reserves and related interest as a result of an IRS settlement and the closure of open tax years. Non-GAAP net income for the fourth quarter of fiscal 2011 was $24.2 million, or $0.96 per diluted share.  Non-GAAP net income for the fourth quarter of fiscal 2010 was $14.9 million, or $0.59 per diluted share. For a complete overview of the differences between GAAP and non-GAAP results, please see the reconciliation table included at the end of our release.

 

Net sales for the third quarter of fiscal 2011 were $210.9 million and net income, on a GAAP basis, was $19.0 million, or $0.74 per diluted share.  Non-GAAP net income for the third quarter of fiscal 2011 was $21.1 million, or $0.83 per diluted share.

 

Bookings received during the fourth fiscal quarter ended October 1, 2011 of $195.4 million increased 1.5% from $192.5 million in the same prior year period and decreased by 14.5% compared to bookings of $228.5 million in the immediately preceding quarter.  The book-to-bill ratio was 0.94, resulting in backlog of $356.5 million at October 1, 2011 compared to a backlog of $368.7 million at July 2, 2011 and a backlog of $262.0 million at October 2, 2010.

 

For the fiscal year ended October 1, 2011, Coherent posted net sales of $802.8 million and net profit of $93.2 million ($3.66 per diluted share) on a GAAP basis compared to the prior year sales of $605.1 million and a net profit on a GAAP

 



 

basis of $36.9 million ($1.47 per diluted share). Bookings received for the fiscal year ended October 1, 2011 were $895.0 million, compared to $696.0 million in bookings received during fiscal 2010.

 

“A solid fourth quarter performance capped off a record-setting year for Coherent including all-time highs for sales, orders, operating income and earnings per share.  We also maintained a very strong balance sheet allowing us to make investments in Germany, Korea and Singapore that should deliver long-term returns as well as returning $100 million to shareholders through share repurchases” said John Ambroseo, Coherent’s President and Chief Executive Officer.  “While we have the usual puts and takes in various markets, the reduction in fourth quarter bookings is almost entirely related to the timing of orders in the FPD market for annealing systems.  This will have little impact on fiscal 2012 revenues for annealing systems as we have very high backlog coverage.  We are working with a number of customers throughout Asia on adding new capacity for FPD production and we expect to receive meaningful orders in fiscal 2012,” he added.

 

Coherent ended the quarter with cash and short term investments of $220.2 million, a decrease of $47.2 million from cash and short term investments of $267.4 million at July 2, 2011 and a decrease of $42.6 million from cash and short term investments of $262.8 million at October 2, 2010. During the quarter and year ended October 1, 2011, we repurchased approximately 1.3 million and 2.1 million shares of common stock at a cost of $58.7 million and $100.1 million, respectively.

 

CONFERENCE CALL REMINDER

 

The Company will host a conference call today to discuss its financial results at 1:30 P.M. Pacific (4:30 P.M. Eastern). A listen-only broadcast of the conference call can be accessed on the Company’s website at either http://www.coherent.com/Investors/ or http://www.earnings.com. For those who are not able to listen to the live broadcast, the call will be archived for approximately three months on both web sites.  A transcript of management’s prepared remarks can be found at http://www.coherent.com/Investors/.

 



 

Summarized statement of operations information is as follows (unaudited, in thousands except per share data):

 

 

 

Three Months Ended

 

Year Ended

 

 

 

October 1,

 

July 2,

 

October 2,

 

October 1,

 

October 2,

 

 

 

2011

 

2011

 

2010

 

2011

 

2010

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

207,961

 

$

210,882

 

$

166,398

 

$

802,834

 

$

605,067

 

Cost of sales (A) (B) (D) (E)

 

118,464

 

120,720

 

96,579

 

452,012

 

344,256

 

Gross profit

 

89,497

 

90,162

 

69,819

 

350,822

 

260,811

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Research & development (A) (B) (D)

 

19,718

 

21,738

 

19,192

 

81,232

 

72,354

 

Selling, general & administrative (A) (B) (C) (D)

 

36,459

 

37,983

 

32,848

 

149,499

 

123,575

 

Intangibles amortization

 

1,879

 

1,851

 

2,044

 

8,082

 

8,002

 

Total operating expenses

 

58,056

 

61,572

 

54,084

 

238,813

 

203,931

 

Income from operations

 

31,441

 

28,590

 

15,735

 

112,009

 

56,880

 

Other income (expense), net(D) (E)

 

(25

)

766

 

(1,000

)

11,820

 

1,099

 

Income before income taxes

 

31,416

 

29,356

 

14,735

 

123,829

 

57,979

 

Provision for income taxes(F)

 

36

 

10,334

 

4,882

 

30,591

 

21,063

 

Net income

 

$

31,380

 

$

19,022

 

$

9,853

 

$

93,238

 

$

36,916

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income per share:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

1.27

 

$

0.76

 

$

0.40

 

$

3.74

 

$

1.49

 

Diluted

 

$

1.25

 

$

0.74

 

$

0.39

 

$

3.66

 

$

1.47

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares used in computation:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

24,697

 

25,066

 

24,677

 

24,924

 

24,718

 

Diluted

 

25,167

 

25,587

 

25,240

 

25,464

 

25,091

 

 


(A)       Stock-related compensation expense included in operating results is summarized below (all footnote amounts are unaudited, in thousands, except per share data):

 

 

 

Three Months Ended

 

Year Ended

 

Stock-related compensation

 

Oct. 1,

 

July 2,

 

Oct. 2,

 

Oct. 1,

 

Oct. 2,

 

expense

 

2011

 

2011

 

2010

 

2011

 

2010

 

Cost of sales

 

$

374

 

$

369

 

$

241

 

$

1,331

 

$

949

 

Research & development

 

390

 

384

 

311

 

1,474

 

1,174

 

Selling, general & administrative

 

2,676

 

2,686

 

1,500

 

10,158

 

6,333

 

Impact on income from operations

 

$

3,440

 

$

3,439

 

$

2,052

 

$

12,963

 

$

8,456

 

 

For the quarters ended October 1, 2011, July 2, 2011, and October 2, 2010, the impact on net income, net of tax was $2,489 ($0.10 per diluted share), $2,112 ($0.08 per diluted share) and $1,864 ($0.07 per diluted share), respectively. For the years ended October 1, 2011 and October 2, 2010, the impact on net income, net of tax was $9,161 ($0.36 per diluted share) and $6,846 ($0.27 per diluted share), respectively.

 



 

(B)       Restructuring costs included in operating results are summarized below:

 

 

 

Three Months Ended

 

Year Ended

 

 

 

Oct. 1,

 

July 2,

 

Oct. 2,

 

Oct. 1,

 

Oct. 2,

 

Restructuring costs

 

2011

 

2011

 

2010

 

2011

 

2010

 

Cost of sales

 

$

 

$

 

$

3,453

 

$

 

$

5,018

 

Research & development

 

 

 

282

 

 

994

 

Selling, general & administrative

 

 

 

861

 

 

2,590

 

Impact on income from operations

 

$

 

$

 

$

4,596

 

$

 

$

8,602

 

 

Restructuring costs for the quarters ended October 1, 2011and July 2, 2011 and the year ended October 1, 2011 were not material to our results of operations and have not been broken out here or in our non-GAAP reconciliation. For the three months and year ended October 2, 2010, the impact on net income, net of tax was $3,209 ($0.13 per diluted share) and $5,786 ($0.23 per diluted share), respectively.

 

(C)       The year ended October 2, 2010 includes $2,185 ($1,438 net of tax ($0.06 per diluted share)) net receipt from the settlement of litigation resulting from our internal stock option investigation.

 

(D)       Changes in deferred compensation plan liabilities are included in cost of sales and operating expenses while gains and losses on deferred compensation plan assets are included in other income (expense) net.  Deferred compensation expense (benefit) included in operating results is summarized below:

 

 

 

Three Months Ended

 

Year Ended

 

Deferred compensation 

 

Oct. 1,

 

July 2,

 

Oct. 2,

 

Oct. 1,

 

Oct. 2,

 

expense (benefit)

 

2011

 

2011

 

2010

 

2011

 

2010

 

Cost of sales

 

$

(50

)

$

13

 

$

 

$

66

 

$

34

 

Research & development

 

(206

)

80

 

15

 

280

 

183

 

Selling, general & administrative

 

(1,390

)

488

 

68

 

2,214

 

1,349

 

Impact on income from operations

 

$

(1,646

)

$

581

 

$

83

 

$

2,560

 

$

1,566

 

 

For the quarters ended October 1, 2011, July 2, 2011 and October 2, 2010, the impact on other income (expense) net from gains or losses on deferred compensation plan assets was expense of $1,763, income of $216 and expense of $74, respectively. For the year ended October 1, 2011 and October 2, 2010, the impact on other income (expense) net was income of $3,123 and income of $745, respectively.

 

(E)         The year ended October 1, 2011 includes $5,918 ($6,113 net of tax ($0.24 per diluted share)) gain from the dissolution of our Finland operations, of which a charge of $593 is recorded in cost of sales and a benefit of $6,511 is recorded in other income (expense), net.

 

(F)         The year ended October 1, 2011 includes a $9,686 ($0.38 per diluted share) benefit from the release of tax reserves and related interest as a result of an IRS settlement and the closure of open tax years and a $1,549 ($0.06 per diluted share) expense due to an increase in valuation allowances against deferred tax assets.

 



 

Summarized balance sheet information is as follows (unaudited, in thousands):

 

 

 

October 1,
2011

 

October 2,
2010

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash, cash equivalents and short-term investments

 

$

220,203

 

$

262,771

 

Restricted cash

 

 

625

 

Accounts receivable, net

 

141,037

 

110,211

 

Inventories

 

152,385

 

113,858

 

Prepaid expenses and other assets

 

67,021

 

55,052

 

Total current assets

 

580,646

 

542,517

 

Property and equipment, net

 

104,504

 

90,339

 

Other assets

 

158,116

 

170,248

 

Total assets

 

$

843,266

 

$

803,104

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Current portion of long-term obligations

 

$

15

 

$

18

 

Accounts payable

 

39,841

 

39,737

 

Other current liabilities

 

122,549

 

92,165

 

Total current liabilities

 

162,405

 

131,920

 

Other long-term liabilities

 

62,860

 

79,721

 

Total stockholders’ equity

 

618,001

 

591,463

 

Total liabilities and stockholders’ equity

 

$

843,266

 

$

803,104

 

 

Reconciliation of GAAP to Non-GAAP net income (unaudited, in thousands, net of tax):

 

 

 

Three Months Ended

 

Year Ended

 

 

 

October 1,
2011

 

July 2,
2011

 

October 2,
2010

 

October 1,
2011

 

October 2,
2010

 

GAAP net income

 

$

31,380

 

$

19,022

 

$

9,853

 

$

93,238

 

$

36,916

 

Stock option investigation and litigation expense (benefit)

 

 

 

 

 

(1,438

)

Stock-related compensation expense

 

2,489

 

2,112

 

1,864

 

9,161

 

6,846

 

Gain on Finland dissolution

 

 

 

 

(6,113

)

 

One-time tax expense (benefit)

 

(9,686

)

 

 

(8,137

)

 

Restructuring costs

 

 

 

3,209

 

 

5,786

 

Non-GAAP net income

 

$

24,183

 

$

21,134

 

$

14,926

 

$

88,149

 

$

48,110

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP net income per diluted share

 

$

0.96

 

$

0.83

 

$

0.59

 

$

3.46

 

$

1.92

 

 

FORWARD-LOOKING STATEMENTS

 

This press release contains forward-looking statements, as defined under the Federal securities laws. These forward-looking statements include the statements in this press release that relate to the timing and achievement of any long-term returns on the Company’s investments in Germany, Korea and Singapore, the impact of timing of orders in the FPD market for annealing systems, the impact of the timing of orders on the Company’s fiscal 2012 revenues, the timing, impact and amount of backlog and the timing of receipt of orders in fiscal 2012. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause our actual results to differ materially and adversely from those expressed in any forward-looking statement.  Factors that could cause

 



 

actual results to differ materially include risks and uncertainties, including, but not limited to, risks associated with any general market recovery, our successful implementation of our customer design wins, our and our customers’ exposure to risks associated with worldwide economic conditions, the ability of our customers to forecast their own end markets, our ability to accurately forecast future periods, customer acceptance and adoption of our new product offerings, continued availability of products and materials from our suppliers, our ability to derive benefits and returns on the Company’s investments in Germany, Korea and Singapore, our ability to timely ship our products and our customers’ ability to accept such shipments, our ability to have our customers qualify our product offerings, and other risks identified in the Company’s SEC filings.  Readers are encouraged to refer to the risk disclosures and critical accounting policies and estimates described in the Company’s reports on Forms 10-K, 10-Q and 8-K, as applicable and as filed from time-to-time by the Company.  Actual results, events and performance may differ materially from those presented herein.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.  The Company undertakes no obligation to update these forward-looking statements as a result of events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

 

Founded in 1966, Coherent, Inc. is a world leader in providing photonics based solutions to the commercial and scientific research markets and part of the Russell 2000. Please direct any questions to Leen Simonet, Chief Financial Officer at 408-764-4161. For more information about Coherent, visit the Company’s Web site at http://www.coherent.com/ for product and financial updates.

 

5100 Patrick Henry Dr. · P. O. Box 54980, Santa Clara, California 95056—0980 · Telephone (408) 764-4000